Skip to main content
TipRanks
Go Ultimate75% OFF

Jamie Mackay Insider Profile

4 Followers

Jamie Mackay, Ten Percent Owner at RepliCel Life Sciences, holds 10.03M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Jamie Mackay Bought 4,021,500 shares of RepliCel Life Sciences on Mar 15, 2023 for an estimated value of $402.15K.

Jamie Mackay's Trading History

REPCF
RepliCel Life Sciences
Mar 15, 2023Ten Percent OwnerInformative Buy402.15K―
REPCF
Insider Shares: 10.03M (1828.77%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 15, 2023Informative BuyC$402.15K4,021,500C$0.10-59.20%―
Jan 06, 2023Informative BuyC$135.00K1,350,000C$0.10-40.70%―
Sep 22, 2022Informative BuyC$380.91K2,116,167C$0.18+28.70%―

You May Also Like

Jamie Mackay insider profile FAQ

What is the percentage of profitable transactions made by Jamie Mackay?
The percentage of profitable transactions made by Jamie Mackay is 33%.
What is the average return per transaction made by Jamie Mackay?
The average return per transaction made by Jamie Mackay is -23.70%.
What stocks does Jamie Mackay hold?
Jamie Mackay holds: REPCF stocks.
What was Jamie Mackay’s latest transaction?
Jamie Mackay’s latest transaction was an Informative Buy of $402.15K.
What was Jamie Mackay's most profitable transaction?
Jamie Mackay’s most profitable transaction was an Informative Buy of REPCF stock on September 22, 2022. The return on the trade was 28.70%.
What is Jamie Mackay's role in RepliCel Life Sciences?
Jamie Mackay's role in RepliCel Life Sciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.